These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1509434)

  • 1. [Infection problems in the leukopenia phase after autologous bone marrow transplantation].
    Rusten L; Kvaløy SO; Jakobsen E; Kvalheim G; Abrahamsen AF; Høiby EA; Sandven P; Lassen J; Bruu AL
    Tidsskr Nor Laegeforen; 1992 May; 112(13):1723-6. PubMed ID: 1509434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.
    Offidani M; Corvatta L; Olivieri A; Rupoli S; Frayfer J; Mele A; Manso E; Montanari M; Centurioni R; Leoni P
    Bone Marrow Transplant; 1999 Nov; 24(10):1079-87. PubMed ID: 10578158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose cytotoxic therapy with autologous bone marrow or peripheral blood progenitor cell transplantation in malignant lymphomas.
    Cucuianu A; D'Hondt L; Collignon J; Verhulst D; Deprijck B; Chatelain C; Doyen C; Bosly A
    Rom J Intern Med; 1995; 33(3-4):211-25. PubMed ID: 8646194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
    Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
    Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of total body irradiation on infections after autologous bone marrow transplantation.
    Callum JL; Brandwein JM; Sutcliffe SB; Scott JG; Keating A
    Bone Marrow Transplant; 1991 Oct; 8(4):245-51. PubMed ID: 1756321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases].
    Zhou SY; Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou AP; Feng FY
    Ai Zheng; 2002 Apr; 21(4):405-8. PubMed ID: 12452021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases.
    Krüger W; Rüssmann B; Kröger N; Salomon C; Ekopf N; Elsner HA; Kaulfers PM; Mack D; Fuchs N; Dürken M; Kabisch H; Erttmann R; Zander AR
    Bone Marrow Transplant; 1999 Mar; 23(6):589-97. PubMed ID: 10217190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of the efficacy of antimicrobial prophylaxis in bone marrow autografts.
    Wimperis JZ; Baglin TP; Marcus RE; Warren RE
    Bone Marrow Transplant; 1991 Nov; 8(5):363-7. PubMed ID: 1768971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involved field radiation, fractionated total body irradiation, high dose cyclophosphamide, and autologous bone marrow transplantation in the treatment of malignant lymphomas.
    Ghalie R; Richman CM; Adler SS; Korenblit AD; Kramer TS; Manson S; Dolce A; Kaizer H
    Bone Marrow Transplant; 1991 Jul; 8(1):41-5. PubMed ID: 1912954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients.
    Mossad SB; Longworth DL; Goormastic M; Serkey JM; Keys TF; Bolwell BJ
    Bone Marrow Transplant; 1996 Aug; 18(2):265-71. PubMed ID: 8864433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow/stem cell transplantation: initial experience at a north Indian referral centre.
    Gupta S; Kumar L; Raju GM; Kochupillai V; Shukla DK
    Natl Med J India; 2000; 13(2):61-6. PubMed ID: 10835851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined high dose chemotherapy with autologous stem cell transplantation and total body radiotherapy for 32 malignant lymphoma patients].
    Wang H; Cui X; Shao Y
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):436-8. PubMed ID: 11810783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
    van Besien K; Margolin K; Champlin R; Forman S
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
    Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
    Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
    Fassas A; Passweg JR; Anagnostopoulos A; Kazis A; Kozak T; Havrdova E; Carreras E; Graus F; Kashyap A; Openshaw H; Schipperus M; Deconinck E; Mancardi G; Marmont A; Hansz J; Rabusin M; Zuazu Nagore FJ; Besalduch J; Dentamaro T; Fouillard L; Hertenstein B; La Nasa G; Musso M; Papineschi F; Rowe JM; Saccardi R; Steck A; Kappos L; Gratwohl A; Tyndall A; Samijn J;
    J Neurol; 2002 Aug; 249(8):1088-97. PubMed ID: 12195460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy.
    Kröger N; Hoffknecht M; Hänel M; Krüger W; Zeller W; Stockschläder M; de Wit M; Weh HJ; Kabisch H; Erttmann R; Zander AR
    Bone Marrow Transplant; 1998 Jun; 21(12):1171-5. PubMed ID: 9674847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
    Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
    Bone Marrow Transplant; 2000 May; 25(10):1021-8. PubMed ID: 10828860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia.
    Schmid H; Henze G; Schwerdtfeger R; Baumgarten E; Besserer A; Scheffler A; Serke S; Zingsem J; Siegert W
    Bone Marrow Transplant; 1993 Dec; 12(6):597-602. PubMed ID: 8136744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.